Arca Biopharma | ABIO - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Amgen USD 2.08B 570M 2026-03
Arca Biopharma USD -31.82M 2.24M 2026-03
Biogen USD 647.3M 269.6M 2026-06
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 10.82B 3.33B 2026-06
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
CSL USD 2.61B 1.21B 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Daiichi Sankyo JPY -6.52B 113.25B 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Grifols EUR 257.85M 190.87M 2024-12
Laboratory Of America USD 8.61B 121.8M 2026-06
Myriad Genetics USD 4.6M 3.4M 2025-12
Otsuka Holdings JPY 130.23B 54.96B 2026-03
Pfizer USD -653M 5.84B 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06